AbbVie Inc (NYSE:ABBV) - Share price - Overview

Stock Report

AbbVie Inc ABBV

Last Price
$88.91

Day Change
-1.04|-1.16%

As of 20/07/2018
19:57:57 EDT | USD
Minimum 15 Minutes Delay.

Last Close89.95
Day Range86.76 - 89.64
Mkt Cap141.10Bil
52-Wk Range69.38 - 125.86
Yield %3.68
ISINUS00287Y1091
Volume11,793,594
P/E22.34
P/S4.81
P/CF13.55

Share Price

Financials
201520162017
More ...
Income Statement
Revenue22,859.0025,638.0028,216.00
Operating Income7,537.009,384.009,592.00
Net Income5,144.005,953.005,309.00
Basic EPS3.153.653.31
Avg. Diluted Shares Outstanding1,6371,6311,603
Balance Sheet
Current Assets16,314.0016,187.0021,223.00
Non Current Assets36,736.0049,912.0049,563.00
Total Assets53,050.0066,099.0070,786.00
Current Liabilities10,894.009,781.0016,641.00
Total Liabilities---
Total Equity3,945.004,636.005,097.00
Cash Flow
Operating Cash Flow7,535.007,041.009,960.00
Capital Expenditure-532.00-479.00-529.00
Free Cash Flow7,003.006,562.009,431.00

In millions, except "Basic EPS". Currency is USD.

Company Profile

AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Sector

Healthcare

Industry

Drug Manufacturers - Major

Stock Style

Large-Blend

Fiscal Year Ends

December

Employees

29,000
Key Stats
More ...
Price/Earning TTM22.60
Price/Book40.17
Price/Sales TTM4.86
Rev Growth (3 year avg)12.23
EPS Growth (3 year avg)-
Operating Margin % TTM33.99
Net Margin % TTM18.82
ROE TTM108.56
Debt/Equity6.07
Dividends
PreviousLatest
More ...
Declared Date15/02/1815/06/18
Ex-Div12/04/1812/07/18
Paid15/05/1815/08/18
Amnt0.960.96
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.